UCB Biosciences Inc.
UCB Biosciences Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0546-2026, Class II) was initiated on May 8, 2026.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 5
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0546-2026 | Class II | cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by | May 8, 2026 |